|You're receiving this email as a valued member of the International Academy of Compounding Pharmacists. Having trouble viewing this email? View it in your browser.
IACP Member Alert
November 8, 2012
IACP is releasing an official statement today from David Miller, RPh, IACP Executive Vice President and CEO, regarding Congressman Edward Markey’s (D-Mass.) Bill on compounding in response to the meningitis outbreak that emanated from contaminated steroid injections prepared by New England Compounding Center. The IACP statement is being distributed this afternoon via PR Newswire to all national news, trade and medical press.
Please click here to view the IACP press release.
With today’s press release distribution, IACP Members may receive news media calls in your local areas. We encourage you to forward media calls regarding the Academy’s statement to IACP for handling.
Please direct media to:
David A. Ball
Ball Consulting Group, LLC
One Gateway Center, Suite 406
Newton, MA 02458
Please email IACP at firstname.lastname@example.org with any questions regarding this press release. Thank you for being an IACP Member and helping to protect, promote & advance our profession.
|4638 Riverstone Blvd., Missouri City, TX 77459
email@example.com | Phone: 281-933-8400 | Toll-Free Referral Line: 800-927-4227
Click here to unsubscribe.
© 2012 International Academy of Compounding Pharmacists. All Rights Reserved.